You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

CLINICAL TRIALS PROFILE FOR SHR4640

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for SHR4640

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT02815839 ↗	Single Dose Study of SHR4640 in Healthy Subjects	Completed	Jiangsu HengRui Medicine Co., Ltd.	Phase 1	The objective of the study is to assess the safety, tolerance, food effect, pharmacokinetic and pharmacodynamic properties of single dose adminstration of SHR4640 in healthy volunteers.
NCT02890966 ↗	Multiple Dose Study of SHR4640 in Healthy Subjects	Completed	Jiangsu HengRui Medicine Co., Ltd.	Phase 1	The objective of the study is to assess the tolerance, pharmacokinetic and pharmacodynamic properties of multiple dose adminstration of SHR4640 in healthy volunteers.
NCT03015948 ↗	A Single Dose Study of SHR4640 in Healthy Male Volunteers	Completed	Atridia Pty Ltd.	Phase 1	This is a single-center, randomized, double-blind, placebo-controlled, single ascending-dose Phase I trial.
NCT03131583 ↗	The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout	Completed	Jiangsu HengRui Medicine Co., Ltd.	Phase 1	The objective of the study is to assess the pharmacodynamic properties of drug-drug of SHR4640, Febuxostat and Colchicine interaction in patients with gout.
NCT03185793 ↗	Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia	Completed	Jiangsu HengRui Medicine Co., Ltd.	Phase 2	The objective of the study is to assess efficacy and safety of SHR4640 in subjects with hyperuricemia.
NCT03211403 ↗	Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level	Completed	Atridia Pty Ltd.	Phase 1	This is a single-Center, randomized, double-Blind, placebo-controlled, multiple ascending-dose Phase I trail.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for SHR4640

Condition Name

Chart
Table

Condition Name
Intervention	Trials
Hyperuricemia	6
Gout	5
Gout; Hyperuricemia	2
Healthy Adult Male Volunteers	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH
Intervention	Trials
Hyperuricemia	10
Gout	4
Arthritis, Gouty	1
Liver Diseases	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SHR4640

Trials by Country

Map
Table

Trials by Country
Location	Trials
China	12
Australia	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SHR4640

Clinical Trial Phase

Chart
Table

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 3	2
Phase 2	3
Phase 1	13
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	9
Unknown status	3
Not yet recruiting	3
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SHR4640

Sponsor Name

Chart
Table

Sponsor Name
Sponsor	Trials
Jiangsu HengRui Medicine Co., Ltd.	16
Atridia Pty Ltd.	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type
Sponsor	Trials
Industry	18
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.